Evidence map›Paper›PMID 24521531›Full record

Trial reportPreventive medicine2014

Can we build an efficient response to the prescription drug abuse epidemic? Assessing the cost effectiveness of universal prevention in the PROSPER trial.

D Max Crowley, Damon E Jones, Donna L Coffman, Mark T Greenberg

Abstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Preventive medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Substance Use Disorders: Population Prevention.Focus (American Psychiatric Publishing) · 2024
    Article
  7. Article
  8. Review
  9. Article
  10. Accelerating Solutions for the Overdose Crisis: an Effectiveness-Implementation Hybrid Protocol for the HEAL Prevention Cooperative.Prevention science : the official journal of the Society for Prevention Research · 2023
    Article
  11. Economic Evaluation Design within the HEAL Prevention Cooperative.Prevention science : the official journal of the Society for Prevention Research · 2023
    Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. A National Cost Analysis of Community Interventions to Prevent Underage Drinking and Prescription Drug Misuse.Prevention science : the official journal of the Society for Prevention Research · 2021
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

D Max CrowleyThe Center for Child and Family Policy, Duke University, Durham, NC 27705, USA.
Damon E JonesThe Prevention Research Center for Promotion of Human Development, The Pennsylvania State University, University Park, PA 16801, USA.
Donna L CoffmanThe Methodology Center, The Pennsylvania State University, University Park, PA 16801, USA.
Mark T GreenbergThe Prevention Research Center for Promotion of Human Development, The Pennsylvania State University, University Park, PA 16801, USA.

Funding

Partnership Model for Diffusion of Proven PreventionR01DA013709 · NIDA · IOWA STATE UNIVERSITY · PI SPOTH, RICHARD · 2002 to 2017
$35.0M
THE REFINEMENT &APPLICATION OF MEDICAL DECISION MAKING IN PREVENTION SCIENCESP50DA010075 · NIDA · PENNSYLVANIA STATE UNIVERSITY-UNIV PARK · PI COFFMAN, DONNA LYNN · 1996 to 2014
$24.5M
PREVENTION AND METHODOLOGY TRAINING (PAMT)T32DA017629 · NIDA · PENNSYLVANIA STATE UNIVERSITY-UNIV PARK · PI Eric D Claus, Rina D Eiden · 2005 to 2026
$9.5M
Strengthening Benefit-Cost Analyses of Substance Abuse PreventionF32DA034501 · NIDA · DUKE UNIVERSITY · PI CROWLEY, DANIEL MAX · 2012 to 2014
$150k
NIDA NIH HHS F32 DA034501NIDA NIH HHS P50 DA010075NIDA NIH HHS P50-DA 010075NIDA NIH HHS R01 DA 013709NIDA NIH HHS R01 DA013709NIDA NIH HHS T32 DA017629NIDA NIH HHS T32 DA 17629
6 · The paper itself

Abstract

purposePrescription drug abuse has reached epidemic proportions. Nonmedical prescription opioid use carries increasingly high costs. Despite the need to cultivate efforts that are both effective and fiscally responsible, the cost-effectiveness of universal evidence-based-preventive-interventions (EBPIs) is rarely evaluated. This study explores the performance of these programs to reduce nonmedical prescription opioid use.

methodsSixth graders from twenty-eight rural public school districts in Iowa and Pennsylvania were blocked by size and geographic location and then randomly assigned to experimental or control conditions (2002-2010). Within the intervention communities, prevention teams selected a universal family and school program from a menu of EBPIs. All families were offered a family-based program in the 6th grade and received one of three school-based programs in 7th-grade. The effectiveness and cost-effectiveness of each school program by itself and with an additional family-based program were assessed using propensity and marginal structural models.

resultsThis work demonstrates that universal school-based EBPIs can efficiently reduce nonmedical prescription opioid use. Further, findings illustrate that family-based programs may be used to enhance the cost-effectiveness of school-based programs.

conclusionsUniversal EBPIs can effectively and efficiently reduce nonmedical prescription opioid use. These programs should be further considered when developing comprehensive responses to this growing national crisis.

Indexed as

Program EvaluationAdolescentChildCost-Benefit AnalysisEvidence-Based PracticeFamilyFamily TherapyFemaleFollow-Up StudiesHumansIowaMaleOpioid-Related DisordersOutcome Assessment, Health CarePennsylvaniaRural PopulationCost-effectivenessNonmedical prescription drug usePrevention economicsSubstance abuseUniversal prevention

Identifiers

PMID24521531
PMCPMC4131945

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.